These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 11190013

  • 1. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
    Flach AJ, Dolan BJ.
    Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
    [Abstract] [Full Text] [Related]

  • 2. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
    Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA.
    Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T.
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [Abstract] [Full Text] [Related]

  • 4. Posterior capsule opacification after phacoemulsification in patients with postoperative steroidal and nonsteroidal treatment.
    Zaczek A, Laurell CG, Zetterström C.
    J Cataract Refract Surg; 2004 Feb; 30(2):316-20. PubMed ID: 15030818
    [Abstract] [Full Text] [Related]

  • 5. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ.
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R, Grosserode R, Cheetham JK, Rosenthal A.
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [Abstract] [Full Text] [Related]

  • 7. Optic edge design as long-term factor for posterior capsular opacification rates.
    Kohnen T, Fabian E, Gerl R, Hunold W, Hütz W, Strobel J, Hoyer H, Mester U.
    Ophthalmology; 2008 Aug; 115(8):1308-14, 1314.e1-3. PubMed ID: 18321585
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification.
    Mukai K, Matsushima H, Gotoh N, Aose M, Satoshi W, Wataru T, Matsui E, Nagata M, Senoo T.
    J Cataract Refract Surg; 2009 Sep; 35(9):1614-8. PubMed ID: 19683162
    [Abstract] [Full Text] [Related]

  • 9. Effect of intraocular lens edge profile on posterior capsule opacification after extracapsular cataract surgery in a developing country.
    Shah A, Spalton DJ, Gilbert C, Vasavada A, Boyce JF, Minassian D, Jayaram H, Mabey D.
    J Cataract Refract Surg; 2007 Jul; 33(7):1259-66. PubMed ID: 17586384
    [Abstract] [Full Text] [Related]

  • 10. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].
    Hessemer V, Schmitt K, Jacobi A.
    Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774
    [Abstract] [Full Text] [Related]

  • 11. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
    Asano S, Miyake K, Ota I, Sugita G, Kimura W, Sakka Y, Yabe N.
    J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
    [Abstract] [Full Text] [Related]

  • 12. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
    Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T.
    J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
    [Abstract] [Full Text] [Related]

  • 13. [Minimally inflammatory cataract surgery].
    Hessemer V, Schmidt KG, Schartner H.
    Klin Monbl Augenheilkd; 1996 Dec; 209(6):331-9. PubMed ID: 9091708
    [Abstract] [Full Text] [Related]

  • 14. Effect of optic material on posterior capsule opacification in intraocular lenses with sharp-edge optics: randomized clinical trial.
    Findl O, Menapace R, Sacu S, Buehl W, Rainer G.
    Ophthalmology; 2005 Jan; 112(1):67-72. PubMed ID: 15629822
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Nd : YAG capsulotomy rates following phacoemulsification with implantation of PMMA, silicone, or acrylic intra-ocular lenses in four European countries.
    Auffarth GU, Brezin A, Caporossi A, Lafuma A, Mendicute J, Berdeaux G, Smith AF, European PCO Study Group.
    Ophthalmic Epidemiol; 2004 Oct; 11(4):319-29. PubMed ID: 15512993
    [Abstract] [Full Text] [Related]

  • 16. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
    Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LS for Cystoid Macular Edema (ACME) Study Group.
    Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
    [Abstract] [Full Text] [Related]

  • 17. Neodymium:YAG capsulotomy rates following phacoemulsification with implantation of PMMA, silicone, and acrylic intraocular lenses.
    Ram J, Kaushik S, Brar GS, Gupta A.
    Ophthalmic Surg Lasers; 2001 Oct; 32(5):375-82. PubMed ID: 11563781
    [Abstract] [Full Text] [Related]

  • 18. The effect of diclofenac sodium ophthalmic solution on intraocular pressure following cataract extraction.
    Strelow SA, Sherwood MB, Broncato LJ, Napier A, Driebe WT, Guy JR, Vickers FF, Mellars K.
    Ophthalmic Surg; 1992 Mar; 23(3):170-5. PubMed ID: 1574284
    [Abstract] [Full Text] [Related]

  • 19. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV, Westfield KC, Chalkley TH.
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [Abstract] [Full Text] [Related]

  • 20. Ketorolac-tobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision.
    Guzey M, Karadede S, Dogan Z, Satici A.
    Ophthalmic Surg Lasers; 2000 Nov; 31(6):451-6. PubMed ID: 11095120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.